Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
Creator
Xia, Xianzhu
Yang, Songtao
Wang, Chong
Yan, Jinghua
Li, Nan
Wong, Gary
Feng, Na
Gai, Weiwei
Gao, Yuwei
Wang, Hualei
Zhao, Yongkun
Zheng, Xuexing
Zhang, Weijiao
Jin, Hongli
Hu, Guixue
Li, Junfu
Zhao, Guoxing
Source
Elsevier; Medline; PMC
abstract
Abstract Middle East respiratory syndrome coronavirus (MERS-CoV) has continued spreading since its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat. Prophylactics and therapies are urgently needed to address this public health problem. We report here the efficacy of a vaccine consisting of chimeric virus-like particles (VLP) expressing the receptor binding domain (RBD) of MERS-CoV. In this study, a fusion of the canine parvovirus (CPV) VP2 structural protein gene with the RBD of MERS-CoV can self-assemble into chimeric, spherical VLP (sVLP). sVLP retained certain parvovirus characteristics, such as the ability to agglutinate pig erythrocytes, and structural morphology similar to CPV virions. Immunization with sVLP induced RBD-specific humoral and cellular immune responses in mice. sVLP-specific antisera from these animals were able to prevent pseudotyped MERS-CoV entry into susceptible cells, with neutralizing antibody titers reaching 1: 320. IFN-γ, IL-4 and IL-2 secreting cells induced by the RBD were detected in the splenocytes of vaccinated mice by ELISpot. Furthermore, mice inoculated with sVLP or an adjuvanted sVLP vaccine elicited T-helper 1 (Th1) and T-helper 2 (Th2) cell-mediated immunity. Our study demonstrates that sVLP displaying the RBD of MERS-CoV are promising prophylactic candidates against MERS-CoV in a potential outbreak situation.
has issue date
2017-04-30
(
xsd:dateTime
)
bibo:doi
10.1016/j.antiviral.2016.12.019
bibo:pmid
28040513
has license
els-covid
sha1sum (hex)
0ea86045c0a8a03ce313440eb1e887f26a85cae3
schema:url
https://doi.org/10.1016/j.antiviral.2016.12.019
resource representing a document's title
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
has PubMed Central identifier
PMC7113847
has PubMed identifier
28040513
schema:publication
Antiviral Research
resource representing a document's body
covid:0ea86045c0a8a03ce313440eb1e887f26a85cae3#body_text
is
schema:about
of
named entity 'susceptible'
named entity 'morphology'
named entity 'Th1'
named entity 'Immunization'
named entity 'structural'
named entity 'CPV'
named entity 'promising'
named entity 'problem'
named entity 'domain'
named entity 'Novel'
named entity 'MERS-COV'
named entity 'ADJUVANTED'
named entity 'SECRETING'
named entity 'IS A'
named entity 'EMERGENCE'
named entity 'CHARACTERISTICS'
named entity 'VACCINE'
named entity 'CANINE PARVOVIRUS'
named entity 'NEUTRALIZING ANTIBODY'
named entity 'VIRUS-LIKE PARTICLES'
named entity 'SPREADING'
named entity 'STRUCTURAL'
named entity 'INDUCE'
named entity 'ENTRY'
named entity 'THREAT'
named entity 'PARVOVIRUS'
named entity 'SITUATION'
named entity 'FUSION'
named entity 'THESE'
named entity 'CELLULAR IMMUNE RESPONSE'
named entity 'BINDING'
named entity 'VIRUS-LIKE PARTICLES'
named entity 'MICE'
named entity 'CHIMERIC VIRUS'
named entity 'RECEPTOR'
named entity 'NOVEL'
named entity 'DOMAIN'
named entity 'DISPLAYING'
named entity 'VACCINE'
named entity 'SPECIFIC'
named entity 'PIG'
named entity 'VLP'
named entity 'CELLS'
named entity 'IMMUNE RESPONSES'
named entity 'ASSEMBLE'
named entity 'DOMAIN'
named entity 'HERE'
named entity 'VACCINATED'
named entity 'IL-2'
named entity 'SPECIFIC'
named entity 'POTENTIAL'
named entity 'EFFICACY'
named entity 'MORTALITY RATE'
named entity 'REACHING'
named entity 'IL-4'
named entity 'PROPHYLACTIC'
named entity 'INDUCED'
named entity 'CHIMERIC'
named entity 'SIMILAR'
named entity 'STRUCTURAL PROTEIN GENE'
named entity 'MICE'
named entity 'RETAINED'
named entity 'VIRIONS'
named entity 'IMMUNIZATION'
named entity 'STUDY'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 8
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software